Panel gives CMAJ editorial independence

Medical association agrees to take over ownership of troubled journal

Written byDoug Payne
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share
The Canadian Medical Association has agreed to give the beleaguered Canadian Medical Association Journal full editorial independence, along with a sweeping set of additional recommendations -- 25 in all -- from an expert panel. The recommendations, which appear after a dispute over editorial independence that saw the departure of the journal's top editors and most of the editorial board, also include taking the journal back from CMA's media holding company, which has tried to make the CMAJ a for-profit publication. Although the report said the panel "has no philosophical objection to a medical journal of the nature of CMAJ being profitable," it expressed concern that "profitability might be identified or inferred as the primary driver, rather than scientific, medical, and editorial integrity." As a result, the report said ownership must revert to the CMA.The panel's report, which is available online, was released on Friday (July 14). It was prepared by an eight-member Governance Review Panel chaired by lawyer Dick Pound. Among the panelists was Catherine DeAngelis, editor of the Journal of the American Medical Association.The CMA had passed the CMAJ to its media holding company in January 2005. In February, 2006, the head of the holding company fired the journal's two senior editors in a dispute over a story that said women who sought the "morning after" pill were being questioned by pharmacists about their sex lives. Over the following two months, several other editors resigned, along with almost the entire editorial board, in a battle over editorial independence.The latest report includes recommendations that would theoretically prevent any such incident from reoccurring. "The CMA should amend the CMAJ Mission Statement to enshrine, as a specific goal and objective of the CMAJ, the principle of editorial integrity, independent of any special interests." The panel also recommended establishing an independent journal oversight committee to act as a buffer between editor and owner. The panel said the journal's editors may let CMA know they are planning to publish a controversial story, but it would be a courtesy, and the CMA should receive no more notice than the media, and should not have a right to respond.The journal had been operating under interim editorship while the panel reviewed more than 100 responses to a general "call for comments," along with input from 17 editorial, publishing, and educational organizations. CMAJ has 69,000 readers, and about 90% of Canadian physicians subscribe to it.CMA president Ruth Collins-Nakai said in a statement that the CMA will now recruit a new editor-in-chief, likely to be in place by the end of the year. Overall, she said that the report "provides a balance between editorial independence and editorial accountability."One of the editorial board members who resigned during the winter disputes, Jerome Kassirer of the Tufts University School of Medicine, told The Scientist that he thinks the panel did "an admirable job," but he is waiting to see who is named Editor-in-Chief before saying the independence issue has been settled. "The report talked about the fact that 'trust and good faith cannot be mandated,'" Kassirer added. "The CMA is a medical organization that has done things such that it cannot be trusted. I can't be confident they will follow the spirit or the letter of this report."For his part, Frank Davidoff, the Editor Emeritus of the Annals of Internal Medicine, who sat as a member of the interim Editorial Board after the mass resignations, told The Scientist he found the report to be "quite solid. It covered all the bases quite well." Doug Payne dpayne@the-scientist.comLinks within this article:Canadian Medical Associationhttp://www.cma.ca/index.cfm/ci_id/121/la_id/1.htmCanadian Medical Association Journal http://www.cmaj.ca/CMAJ Governance Review Report http://www.cma.ca/multimedia/cma/content_images/Inside_cma/Media_Release/pdf/2006/GovernanceReviewPanel.pdf"Panel Mandate and Terms of Reference" http://www.cma.ca/multimedia/cma/content_images/Inside_cma/Media_Release/pdf/2006/GovernanceReviewPanelAppendices.pdfA.McCook, "Canadian journal fires top editors," The Scientist, February 22, 2006. http://www.the-scientist.com/news/display/23140/L. Eggertson and B. Sibbald, "Privacy issues raised over Plan B: Women asked for names, addresses, sexual history," Canadian Medical Association Journal, December 2, 2005. http://www.cmaj.ca/cgi/rapidpdf/cmaj.051461v1.pdfD Payne, "Resignations at embattled Canadian journal," The Scientist, March 1, 2006 http://www.the-scientist.com/news/display/23176/D Payne, "CMAJ loses most of its Editorial Board", The Scientist, March 16, 2006 http://www.the-scientist.com/news/display/23234/"CMA accepts all recommendations from panel reviewing CMAJ's structure" http://www.cma.ca/index.cfm/ci_id/10035299/la_id/1.htm
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies